A trial in healthy participants to examine the safety, tolerability, and pharmacokinetics of orally administered FT751
This research study is looking for healthy adult volunteers to test a new medicine called FT751. This medicine is being developed to treat inflammatory diseases, which are conditions where your body's immune system mistakenly attacks its own tissues. This is the very first time this medicine will be given to people, so it's a very early stage of testing. The main goals are to check if the medicine is safe when taken by mouth, to see how well people can tolerate it (meaning, if they have any side effects), and to understand how the body absorbs, uses, and gets rid of the medicine. This information is crucial for deciding if the medicine can be tested further in people who actually have inflammatory diseases.
At a glance
What is this study about?
This research study is about a new medicine called FT751. It's designed to help people with what are called 'inflammatory diseases'. These are conditions, like arthritis or Crohn's disease, where your body's immune system gets a bit confused and starts attacking healthy parts of itself, causing pain and swelling.
Before any new medicine can be given to patients who are unwell, doctors need to make sure it's safe. That's why, in this very first stage of testing, they are looking for healthy volunteers. By giving the medicine to people who are healthy, doctors can carefully watch for any side effects and learn how the medicine behaves in the body without the added complications of an existing illness.
Think of it like testing a car's engine for the first time. You wouldn't put it straight into a race car. You'd test it in a controlled environment first to make sure it runs properly and safely. Similarly, this study helps doctors understand if FT751 is safe, how much of it the body takes in, how long it stays in the body, and how it's removed. This information is really important because it helps scientists decide if the medicine is promising enough to move on to the next stages of testing, eventually with people who have inflammatory diseases.
Key takeaways
- This is an early-stage study testing a new medicine (FT751) for inflammatory diseases.
- It's the first time the medicine will be given to people, focusing on safety and how the body handles it.
- They are looking for healthy adults (male and female, aged 18+) to volunteer.
- Participation involves taking the medicine by mouth and having regular health checks.
- There's no direct health benefit for volunteers, but you'll help advance medical knowledge.
Who may be eligible?
To join this study, you need to be a healthy adult aged 18 or older. Both men and women are welcome to take part. Researchers are looking for people who are generally well and don't have any major ongoing health problems.
Because this is an early study testing a new medicine for the very first time in humans, there will be strict rules about who can join. This is to make sure everyone involved is kept as safe as possible. For example, if you have certain medical conditions, take specific medications, or have known allergies, you might not be able to participate. You would also need to be able to understand the study and be willing to follow all its instructions.
The research team will review your health history and do some health checks to confirm if this study is right for you. It's important to be completely open and honest about your health if you are considering taking part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy with no major ongoing medical conditions?
- Are you able to speak and understand English?
- Are you willing to attend regular appointments at a clinic?
- Are you willing to take an experimental medicine by mouth?
What does participation involve?
If you decide to take part, you'll be given the new medicine, FT751, by mouth. This will involve several visits to a clinic or research center over a set period. During these visits, the study team will carefully monitor your health. They might take blood samples, check your blood pressure and heart rate, and ask you about how you are feeling and if you have any side effects.
The total amount of time you will be involved in the study will depend on the specific plan, but it generally involves regular check-ups and follow-up after you stop taking the medicine. All the details, including how often you'll need to visit and for how long, will be clearly explained to you before you agree to join.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What are inflammatory diseases?
These are conditions where your body's defence system mistakenly attacks healthy tissues, causing symptoms like pain, swelling, and redness. Examples include rheumatoid arthritis or Crohn's disease.
Why is this medicine being tested on healthy people?
This is the very first time the medicine will be used in humans. Testing on healthy volunteers helps researchers safely understand how the medicine behaves in the body and check for side effects without other health problems complicating the results.
Will I get better if I join this study?
As a healthy volunteer, you're not expected to have any illness that needs treating, so there's no direct health improvement expected for you personally. Your involvement helps future patients.
What does 'orally administered' mean?
It simply means the medicine will be given by mouth, usually as a tablet or capsule that you swallow.
Will I be paid to take part?
Sometimes, studies offer payments for your time and travel, but this varies. You should ask the study team if this applies to this particular study.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.